53-41-8C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12QGXBDMJGAMFCBF-HLUDHZFRSA-N164.08 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];172.06 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];194.11 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
166.6 Ų [M+H-H2O]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)];176.71 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 4.1% (3 of 73) of reports.
Danger
H315 (94.5%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (94.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H334 (93.2%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory];H335 (93.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P233, P260, P261, P264, P264+P265, P271, P280, P284, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 73 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 3 of 73 reports by companies.;There are 5 notifications provided by 70 of 73 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Chemical: Androstan-17-one, 3-hydroxy-, (3.alpha.,5.alpha.)-
Androstan-17-one, 3-hydroxy-, (3.alpha.,5.alpha.)-: Does not have an individual approval but may be used under an appropriate group standard
解説男性ホルモンであるテストステロンの代謝産物の一つで,テストステロンより弱いがアンドロゲンとしての活性をもつ. A.F.J.ブーテナントらにより成年男子尿から単離された (1934) 男性ホルモン。融点 185~185.5℃の無色結晶。水には難溶であるが,多くの有機溶媒には易溶。男性ホルモン作用の国際単位の基準物質で,その 0.1mgによる去勢雄鶏のとさか部面積の増加の程度に等しい作用を1国際単位としている。生物活性はテストステロンの約1/10程度。 L.S.ルジチカらによりコレステリンから合成され (34) ,構造が確定した。
用途科学研究においてアンドロステロンは行動生物学や化学コミュニケーションの分野で活用されていますまた香料産業ではその独特の香りがフレグランスの成分として用いられることもありますさらに医学的な視点からはホルモンバランスの研究や疾患の診断にも利用されることがあります
使用It was isolated from male urine after removed of the phenolic estrogen fraction.
純化方法Crystallise androsterone from Me2CO/Et2O or Me2CO and sublime it in high vacuum. The acetate [1164-95-0] crystallises from Et2O, Me2CO/Et2O or aqueous EtOH and sublimes in high vacuum with m 165-166o, [] D 25 +87o (c 2, EtOH). [Ruzicka Helv Chim Acta 17 1389 1934, Marker J Am Chem Soc 57 1755 1935, Gnds & Orr J Chem Soc Chem Commun 1239 1982, Beilstein 8 IV 462.]
読み込み中…
53-41-8DTXSID3036525CHEMBL87285CHEBI:16032化学的特性white to light beige crystalline powder
cis-Androsterone
Hormone
Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP
Chemical: Androstan-17-one, 3-hydroxy-, (3.alpha.,5.alpha.)-
Androstan-17-one, 3-hydroxy-, (3.alpha.,5.alpha.)-: Does not have an individual approval but may be used under an appropriate group standard
定義ChEBI: An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone .